Study Identifies Single microRNA Biomarker for Prognosis of Mesothelioma Patients 18 February 2010 Demonstrate potential of miR-29c* to act as an independent prognostic factor for time to progression as well as survival after surgery.
Automating Viral RNA Genotyping 18 February 2010 Agilent Automation Solutions has released a new applications bulletin that describes an automated system for rapid characterization of pathogens, including for example the Influenza A (H1N1) virus.
PBL InterferonSource: 20 Years of Interferon Excellence 18 February 2010 Celebrating the 20th anniversary of its expertise in the field of interferons
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients 17 February 2010 Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
MDRNA, Inc. Reports Positive Results for its Proprietary siRNA Delivery Technology 09 February 2010 Data demonstrates the potential for long-term stability of drug products.
Mirrx Therapeutics Secures Seed Financing for Development of microRNA- blocking Technology 09 February 2010 Finances will enable the company to achieve in vivo proof of concept for its microRNA-blocking Blockmir technology.
OGI Announces Genomics Technology Seeding Award to UHN Microarray Centre 08 February 2010 UHN Microarray Centre will receive $10,000 to evaluate several RNA amplification methods to extend the applicability of the nCounter™ system.
QIAGEN Unit and Pfizer Collaborates to Develop a Companion Diagnostic for Brain Tumor Patients 08 February 2010 Both companies have entered into an agreement to develop a companion diagnostic test kit for PF-04948568.